Facing the XBB.15 Variant: Enterprises and the European Commission’s Approval

Enterprises – Facing the XBB.15 variant

Versus the XBB.15 variant

The European Commission has approved the third update of the prophylactic, used under the trade name of ‘Comirnaty’.

The European Commission has given the go-ahead to the adaptation of the BionTech-Pfizer vaccine against the new coronavirus subvariant omicron XBB.1. Photo: EUROPEAN UNION.
2023-09-02 08:22:12
#Free #Europe #adaptation #Pfizer #vaccine #covid